Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review

British Journal of Pharmacology

Volumn 174, Issue 11, 2017, Pages 1378-1394

  Cicero, Arrigo F G ^a   Fogacci, Federica ^a   Colletti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAPEPTIDE; PEPTIDE DERIVATIVE; PEPTIDE;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; BLOOD PRESSURE REGULATION; CHRONIC DISEASE; DRUG EFFECT; DYSLIPIDEMIA; HUMAN; HYPERTENSION; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIGAND BINDING; MALIGNANT NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ADMINISTRATION AND DOSAGE; ANIMAL; CARDIOVASCULAR DISEASE; DIET THERAPY; DIETARY SUPPLEMENT; INFECTION; ISOLATION AND PURIFICATION; NEOPLASM; PHARMACOLOGY; PROTEIN INTAKE;

ANIMALS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIETARY PROTEINS; DIETARY SUPPLEMENTS; HUMANS; INFECTION; NEOPLASMS; PEPTIDES;

EID: 84990048315     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13608     Document Type: Review

References (129)

1. Aihara K, Ishii H, Yoshida M (2009). Casein-derived tripeptide, Val-Pro-Pro (VPP), modulates monocyte adhesion to vascular endothelium. J Atheroscler Thromb 16: 594–603.
2. Alemán A, Pérez-Santín E, Bordenave-Juchereau S, Arnaudin I, Gómez-Guillén MC, Montero P (2011). Squid gelatin hydrolysates with antihypertensive, anticancer and antioxidant activity. Food Res Int 44: 1044–1051.
3. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5729–5143.
4. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
5. Alexander SPH, Peters JA, Kelly E, Marrion N, Benson HE, Faccenda E et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Other ion channels. Br J Pharmacol 172: 5942–5955.
6. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015d). The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 172: 6110–6202.
7. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015e). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
8. Altorf-van der Kuil W, Engberink MF, Brink EJ, van Baak MA, Bakker SJ, Navis G et al. (2010). Dietary protein and blood pressure: a systematic review. PLoS One 5: e12102.
9. Aluko RE (2015). Antihypertensive peptides from food proteins. Annu. Rev Food Sci Technol 6: 235–262.
10. Anderson HJ, Coleman JE, Andersen RJ, Roberge M (1997). Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemother Pharmacol 39: 223–226.
11. Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren E et al. (2000). Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol Biomarkers Prev 9: 43–47.
12. Azuma N, Suda H, Iwasaki H, Yamagata N, Saeki T, Kanamoto R et al. (2000). Antitumorigenic effects of several food proteins in a rat model with colon cancer and their reverse correlation with plasma bile acid concentration. J Nutr Sci Vitaminol 46: 91–96.
13. Bai R, Pettit GR, Hamel E (1990). Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem Pharmacol 39: 1941–1949.
14. Bhat ZF, Kumar S, Bhat HF (2015). Bioactive peptides of animal origin: a review. J Food Sci Technol 52: 5377–5392.
15. Blanco-Míguez A, Gutiérrez-Jácome A, Pérez-Pérez M, Pérez-Rodríguez G, Catalán-García S, Fdez-Riverola F et al. (2016). From amino acid sequence to bioactivity: scientific evidence on antitumor peptides. Protein Sci. doi:10.1002/pro.2927.
16. Boohaker RJ, Lee MW, Vishnubhotla P, Perez JM, Khaled AR (2012). The use of therapeutic peptides to target and to kill cancer cells. Curr Med Chem 19: 3794–3804.
17. Borghi C, Cicero AF (2016). Nutraceuticals with clinically detectable blood pressure lowering effect: a review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol. doi:10.1111/bcp.12902.
18. Butteiger DN, Hibberd AA, McGraw NJ, Napawan N, Hall-Porter JM, Krul ES (2016). Soy protein compared with milk protein in a western diet increases gut microbial diversity and reduces serum lipids in golden Syrian hamsters. J Nutr 146: 697–705.
19. Cam A, de Mejia EG (2012). RGD-peptide lunasin inhibits Akt-mediated NF-κB activation in human macrophages through interaction with the αVβ3 integrin. Mol Nutr Food Res 56: 1569–1581.
20. Chakrabarti S, Jahandideh F, Wu J (2014). Food-derived bioactive peptides on inflammation and oxidative stress. Biomed Res Int 2014: 608979.
21. Chang HC, Lewis D, Tung CY, Han L, Henriquez SMP, Voiles L et al. (2014). Soypeptide lunasin in cytokine immunotherapy for lymphoma. Cancer Immunol Immunother 63: 283–295.
22. Chen YW, Huang SC, Lin-Shiau SY, Lin JK (2005). Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26: 1296–1306.
23. Cheung RC, Ng TB, Wong JH (2015). Marine peptides: bioactivities and applications. Mar Drugs 13: 4006–4043.
24. Cho SJ, Juillerat MA, Lee CH (2007). Cholesterol lowering mechanism of soybean protein hydrolysate. J Agric Food Chem 55: 10599–10604.
25. Cicero AF, Colletti A (2015a). Nutraceuticals and blood pressure control: results from clinical trials and meta-analyses. High Blood Press Cardiovasc Prev 22: 203–213.
26. Cicero AF, Colletti A (2015b). Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: the available clinical data. Phytomedicine Nov 10. pii: S0944-7113(15)00330-X. doi:10.1016/j.phymed.2015.10.011.
27. Cicero AF, Gerocarni B, Laghi L, Borghi C (2011a). Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J Hum Hypertens 25: 425–436.
28. Cicero AF, Rosticci M, Gerocarni B, Bacchelli S, Veronesi M, Strocchi E et al. (2011b). Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial. Hypertens Res 34: 1035–1040.
29. Cicero AF, Aubin F, Azais-Braesco V, Borghi C (2013). Do the lactotripeptides isoleucine–proline–proline and valine–proline–proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens 26: 442–449.
30. Cicero AF, Colletti A, Rosticci M, Cagnati M, Urso R, Giovannini M et al. (2016). Effect of lactotripeptides (isoleucine-proline-proline/valine-proline-proline) on blood pressure and arterial stiffness changes in subjects with suboptimal blood pressure control and metabolic syndrome: A double-blind, randomized, crossover clinical trial. Metab Syndr Relat Disord 14: 161–166.
31. Craik DJ, Fairlie DP, Liras S, Price D (2013). The future of peptide-based drugs. Chem Biol Drug Des 81: 136–147.
32. Damiens E, Yazidi I, Mazurier J, Duthile I, Spik G, Boilly-Marer Y (1999). Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486–498.
33. de Mejía EG, Dia VP (2010). The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells. Cancer Metast Rev 29: 511–528.
34. de Mejia EG, Wang W, Dia VP (2010). Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3. Mol Nutr Food Res 54: 406–414.
35. Deng M, Zhang W, Tang H, Ye Q, Liao Q, Zhou Y et al. (2013). Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms. Oncogene 32: 4273–4283.
36. Dia VP, de Mejia EG (2011). Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling. Cancer Lett 313: 167–180.
37. Dia VP, Mejia EG (2010). Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression. Cancer Lett 295: 44–53.
38. Dia VP, Wang W, Oh VL, de Lumen BO, de Meja EG (2009). Isolation, purification and characterization of lunasin from defatted soybean flour and in vitro evaluation of its antinflammatory activity. Food Chem 114: 108–115.
39. Dong JY, Szeto IM, Makinen K, Gao Q, Wang J, Qin LQ et al. (2013). Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 110: 1188–1194.
40. Duarte J, Vinderola G, Ritz B, Perdigon G, Matar C (2006). Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation. Immunobiology 211: 341–350.
41. Fast J, Mossberg AK, Nilsson H, Svanborg C, Akke M, Linse S (2005). Compact oleic acid in HAMLET. FEBS Lett 579: 6095–6100.
42. Franck P, Moneret Vautrin DA, Dousset B, Kanny G, Nabet P, Guénard-Bilbaut L et al. (2002). The allergenicity of soybean-based products is modified by food technologies. Int Arch Allergy Immunol 128: 212–219.
43. García-Fernández LF, Losada A, Alcaide V, Alvarez AM, Cuadrado A, González L et al. (2002). Aplidine induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta. Oncogene 21: 7533–7544.
44. Garcia-Nebot MJ, Recio I, Hernandez-Ledesma B (2014). Antioxidant activity and protective effects of peptide lunasin against oxidative stress in intestinal Caco-2 cells. Food Chem Toxicol 65: 155–161.
45. Gautam A, Kapoor P, Chaudhary K, Kumar R, Raghava GP (2014). Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics. Curr Med Chem 21: 2367–2391.
46. Gildberg A, Bøgwald J, Johansen A, Stenberg E (1996). Isolation of acid peptide fractions from a fish protein hydrolysate with strong stimulatory effect on Atlantic salmon (Salmo salar) head kidney leucocytes. Comp Biochem Physiol B Biochem Mol Biol 114: 97–101.
47. Harada K, Maeda T, Hasegawa Y, Tokunaga T, Tamura Y, Koizumi T (2010). Antioxidant activity of fish sauces including puffer (Lagocephalus wheeleri) fish sauce measured by the oxygen radical absorbance capacity method. Mol Med Rep 3: 663–668.
48. Hartmann R, Meisel H (2007). Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 18: 163–169.
49. Hata I, Higashiyama S, Otani H (1998). Identification of a phosphopeptide in bovine alpha s1-casein digest as a factor influencing proliferation and immunoglobulin production in lymphocyte cultures. J Dairy Res 65: 569–578.
50. Hatzoglou A, Bakogeorgou E, Hatzoglou CM, Martin P, Castanas E (1996). Antiproliferative and receptor binding properties of α- and β-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol 310: 217–223.
51. Hernandez-Ledesma B, Hsieh CC (2015). Chemopreventive role of food-derived proteins and peptides: a review. Crit Rev Food Sci Nutr. doi:10.1080/10408398.2015.1057632.
52. Hernandez-Ledesma B, Hsieh CC, de Lumen BO (2009). Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem Biophys Res Commun 390: 803–808.
53. Hernández-Ledesma B, Hsieh CC, de Lumen BO (2013). Chemopreventive properties of peptide lunasin: a review. Protein Pept Lett 20: 424–432.
54. Herrera Chalé F, Ruiz Ruiz JC, Betancur Ancona D, Acevedo Fernández JJ, Segura Campos MR (2016). The hypolipidemic effect and antithrombotic activity of Mucuna pruriens protein hydrolysates. Food Funct 7: 434–444.
55. Hipkiss AR, Brownson C (2000). A possible new role for the anti-ageing peptide carnosine. Cell Mol Life Sci 7: 747–753.
56. Holmer-Jensen J, Karhu T, Mortensen LS, Pedersen SB, Herzig KH, Hermansen K (2011). Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects. Nutr J 10: 115.
57. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013). Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13: 714–726.
58. Houston MC (2013). The role of nutrition, nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Altern Ther Health Med 19 (Suppl. 1): 32–49.
59. Hsieh CC, Hernández-Ledesma B, de Lumen BO (2010). Soybean peptide lunasin suppresses in vitro and in vivo 7,12-dimethylbenz[a]anthracene-induced tumorigenesis. J Food Sci 75: H311–H316.
60. Hsu KC, Li-Chan ECY, Jao CL (2011). Antiproliferative activity of peptides prepared from enzymatic hydrolysates of tuna dark muscle on human breast cancer cell line MCF-7. Food Chem 126: 617–622.
61. Hu X, Song L, Huang L, Zheng Q, Yu R (2012). Antitumor effect of a polypeptide fraction from Arca subcrenata in vitro and in vivo. Mar Drugs 10: 2782–2794.
62. Ichikawa S, Morifuji M, Ohara H, Matsumoto H, Takeuchi Y, Sato K (2010). Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate. Int J Food Sci Nutr 61: 52–60.
63. Iwai K, Hasegawa T, Taguchi Y, Morimatsu F, Sato K, Nakamura Y et al. (2005). Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem 53: 6531–6536.
64. Jang A, Jo C, Kang KS, Lee M (2008). Antimicrobial and human cancer cell cytotoxic effect of synthetic angiotensin-converting enzyme (ACE) inhibitory peptides. Food Chem 107: 327–336.
65. Jeong HJ, Jeong JB, Hsieh CC, Hernàndez-Ledesma B, de Lumen BO (2010). Lunasin is prevalent in barley and is bioavailable and bioactive in in vivo and in vitro studies. Nutr Cancer 62: 1113–1119.
66. Jeong HJ, Lam Y, de Lumen BO (2002). Barley lunasin suppresses ras-induced colony formation and inhibits acetylation in mammalian cells. J Agric Food Chem 50: 5903–5908.
67. Kannan A, Hettiarachchy NS, Lay JO, Liyanage R (2010). Human cancer cell proliferation inhibition by a pentapeptide isolated and characterized from ricebran. Peptides 31: 1629–1634.
68. Kitts DD, Weiler K (2003). Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Des 9: 1309–1323.
69. Lahov E, Regelson W (1996). Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem Toxicol 34: 131–145.
70. Lammi C, Zanoni C, Scigliuolo GM, D'Amato A, Arnoldi A (2014). Lupin peptides lower low-density lipoprotein (LDL) cholesterol through an up-regulation of the LDL receptor/sterol regulatory element binding protein 2 (SREBP2) pathway at HepG2 cell line. J Agric Food Chem 62: 7151–7159.
71. Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG et al. (2012). Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 22: 463–470.
72. Lule VK, Garg S, Pophaly SD, Hitesh, Tomar SK (2015). Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide. J Food Sci 80: R485–R494.
73. Ma J, Huang F, Lin H, Wang X (2013). Isolation and purification of a peptide from Bullacta exarata and its impaction of apoptosis on prostate cancer cell. Mar Drugs 11: 266–273.
74. Ma YH, Cheng WZ, Gong F, Ma AL, Yu QW, Zhang JY et al. (2008). Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses. World J Gastroenterol 14: 5274–5281.
75. Mader JS, Hoskin DW (2006). Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15: 933–946.
76. Majumder K, Chakrabarti S, Morton JS, Panahi S, Kaufman S, Davidge ST et al. (2013). Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PLoS One 8: e82829.
77. Majumder K, Mine Y, Wu J (2016). The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases. J Sci Food Agric 96: 2303–2311.
78. Malaguti M, Dinelli G, Leoncini E, Bregola V, Bosi S, Cicero AF et al. (2014). Bioactive peptides in cereals and legumes: agronomical, biochemical and clinical aspects. Int J Mol Sci 15: 21120–21135.
79. Malinowski J, Klempt M, Clawin-Rädecker I, Lorenzen PC, Meisel H (2014). Identification of a NFκB inhibitory peptide from tryptic β-casein hydrolysate. Food Chem 165: 129–133.
80. Malkowicz SB, McKenna WG, Vaughn DJ, Wan XS, Propert KJ, Rockwell K et al. (2001). Effects of Bowman-Birk inhibitorconcentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate 48: 16–28.
81. Marcone S, Belton O, Fitzgerald DJ (2016). Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis. Br J Clin Pharmacol. doi:10.1111/bcp.13002.
82. Marques MR, Soares Freitas RA, Corrêa Carlos AC, Siguemoto ÉS, Fontanari GG, Arêas JA (2015). Peptides from cowpea present antioxidant activity, inhibit cholesterol synthesis and its solubilisation into micelles. Food Chem 168: 288–293.
83. Marsh TG, Straub RK, Villalobos F, Hong MY (2011). Soy protein supports cardiovascular health by downregulating hydroxymethylglutaryl-coenzyme A reductase and sterol regulatory element-binding protein-2 and increasing antioxidant enzyme activity in rats with dextran sodium sulfate-induced mild systemic inflammation. Nutr Res 31: 922–928.
84. Motoi H, Kodama T (2003). Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung 47: 354–358.
85. Nirupama G, Mohammad B, Hossain DKR, Nigel PB (2015). A review of extraction and analysis of bioactives in oat and barley and scope for use of novel food processing technologies. Molecules 20: 10884–10909.
86. Nongonierma AB, FitzGerald RJ (2015). Bioactive properties of milk proteins in humans: a review. Peptides 73: 20–34.
87. Orsi N (2004). The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17: 189–196.
88. Otvos L Jr (2008). Peptide-based drug design: here and now. Methods Mol Biol 494: 1–8.
89. Park JH, Jeong HJ, de Lumen BO (2005a). Contents and bioactivities of lunasin, bowman-birk inhibitor, and isoflavones in soybean seed. J Agric Food Chem 53: 7686–7690.
90. Park VV, Koo MS, Kasymova TD, Kwon DY (2005b). Isolation and identification of peptides from soy 11S-globulin with hypocholesterolemic activity. Chem Nat Comp 41: 710–714.
91. Perego S, Cosentino S, Fiorilli A, Tettamanti G, Ferraretto A (2012). Casein phosphopeptides modulate proliferation and apoptosis in HT-29 cell line through their interaction with voltage-operated L-type calcium channels. J Nutr Biochem 23: 808–816.
92. Pihlanto A (2006). Antioxidative peptides derived from milk proteins. Int Dairy J 16: 1306–1314.
93. Pihlanto-Leppälä A (2000). Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci Technol 11: 347–356.
94. Pownall TL, Udenigwe CC, Aluko RE (2010). Amino acid composition and antioxidant properties of pea seed (Pisum sativumL.) enzymatic protein hydrolysate fractions. J Agric Food Chem 58: 4712–4718.
95. Rotimi EA (2015). Antihypertensive Peptides from Food Proteins. Annu Rev Food Sci Technol 6: 235–262.
96. Rutherfurd-Markwick KJ (2012). Food proteins as a source of bioactive peptides with diverse functions. Br J Nutr 108 (Suppl. 2): S149–S157.
97. Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K et al. (2007). Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43. Cancer Lett 253: 249–257.
98. Sato K, Egashira Y, Ono S, Mochizuki S, Shimmura Y, Suzuki Y et al. (2013). Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rats. J Agric Food Chem 61: 6304–6310.
99. Sava G (1989). Reduction of B16 melanoma metastases by oral administration of egg-whitelysozyme. Cancer Chemother Pharmacol 25: 221–222.
100. Sava G, Pacor S, Dasic G, Bergamo A (1995). Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas. Anticancer Res 15: 1883–1888.
101. Schweizer F (2009). Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 625: 190–194.
102. Seifert G, Jesse P, Laengler A, Reindl T, Lüth M, Lobitz S et al. (2008). Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer Lett 264: 218–228.
103. Shigemura Y, Iwai K, Morimatsu F, Iwamoto T, Mori T, Oda C et al. (2009). Effect of prolyl-hydroxyproline (Pro–Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J Agric Food Chem 57: 444–449.
104. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin 63: 11–30.
105. Sirtori CR, Arnoldi A, Cicero AF (2015). Nutraceuticals for blood pressure control. Ann Med 47: 447–456.
106. Sirtori CR, Triolo M, Bosisio R, Bondioli A, Calabresi L, De Vergori V et al. (2012). Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals. Br J Nutr 107: 1176–1183.
107. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
108. Souza Lda C, Camargo R, Demasi M, Santana JM, de Sá CM, de Freitas SM (2014). Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells. PLoS One 9: e86600.
109. Sun X, Jiang R, Przepiorski A, Reddy S, Palmano KP, Krissansen GW (2012). Iron-saturated bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice. BMC Cancer 12: 591.
110. Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R (2005). Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice. Oncol Rep 13: 1247–1250.
111. Teschemacher H (2003). Opioid receptor ligands derived from food proteins. Curr Pharm Des 9: 1331–1344.
112. Thundimadathil J (2012). Cancer treatment using peptides: current therapies and future prospects. J Amino Acids 2012: 967347.
113. Ting CH, Huang HN, Huang TC, Wu CJ, Chen JY (2014). The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS. Biomaterials 35: 3627–3640.
114. Tokede OA, Onabanjo TA, Yansane A, Gaziano JM, Djoussé L (2015). Soya products and serum lipids: a meta-analysis of randomised controlled trials. Br J Nutr 114: 831–843.
115. Tyagi A, Tuknait A, Anand P, Gupta S, Sharma M, Mathur D et al. (2015). CancerPPD: a database of anticancer peptides and proteins. Nucl Acids Res 43: D837–D843.
116. Udenigwe CC, Aluko RE (2012). Food protein-derived bioactive peptides: production, processing, and potential health benefits. J Food Sci 77: R11–R24.
117. Valadez-Vega C, Alvarez-Manilla G, Riverón-Negrete L, García-Carrancá A, Morales-González JA, Zuñiga-Pérez C et al. (2011). Detection of cytotoxic activity of lectin on human colon adenocarcinoma (Sw480) and epithelial cervical carcinoma (C33-A). Molecules 16: 2107–2118.
118. Varadhachary A, Wolf JS, Petrak K, O'Malley BW Jr, Spadaro M, Curcio C et al. (2004). Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 111: 398–403.
119. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010). Synthetic therapeutic peptides: science and market. Drug Discov Today 15: 40–56.
120. Wang J, Zhao M, Zhao Q, Jiang Y (2007). Antioxidant properties of papain hydrolysates of wheat gluten in different oxidation systems. Food Chem 101: 1658–1663.
121. Wang YK, He HL, Wang GF, Wu H, Zhou BC, Chen XL et al. (2010). Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice. Mar Drugs 8: 255–268.
122. Watanabe K, Tsuge Y, Shimoyamada M, Ogama N, Ebina T (1998). Antitumor effects of pronase-treated fragments, glycopeptides, from ovomucin in hen egg white in a double grafted tumor system. J Agric Food Chem 46: 3033–3038.
123. Yadav JS, Yan S, Pilli S, Kumar L, Tyagi RD, Surampalli RY (2015). Cheese whey: A potential resource to transform into bioprotein, functional/nutritional proteins and bioactive peptides. Biotechnol Adv 33 (6 Pt 1): 756–774.
124. Yamauchi R, Ohinata K, Yoshikawa M (2003). Beta-lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor. Peptides 24: 1955–1961.
125. Yang Y, Zhang Z, Pei X, Han H, Wang J, Wang L et al. (2009). Immunomodulatory effects of marine oligopeptide preparation from chum salmon (Oncorhynchus keta) in mice. Food Chem 113: 464–470.
126. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K, Azuma I (1997). Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88: 184–190.
127. Yoshikawa M (2015). Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects. Peptides 72: 208–225.
128. Zannad F, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L, De Backer G et al. (2012). Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a cardiovascular clinical trialists (CVCT) workshop of the ESC working group on cardiovascular pharmacology and drug therapy. ESC working group on cardiovascular pharmacology and drug therapy. Eur J Prev Cardiol 19: 1454–1464.
129. Zhan KX, Jiao WH, Yang F, Li J, Wang SP, Li YS et al. (2014). Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis. J Nat Prod 77: 2678–2684.